Position
Fidelity in X4 Pharmaceuticals, Inc
Back to the book · All holders of XFOR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $4.38M$4.13 → $4.67
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 8.5M | $34M | — | — | — | 0.0% |
| Q1 2026 | 8.1M | $33.5M | $4.13 | $1.05M | −$1.58M | 0.0% |
| Q2 2026 | 8.32M | $38.9M | $4.67 | $4.38M | $1.02M | 0.0% |